Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China.

Xueqing DouWenhui ZhangMan-Chiu Poon Xinsheng Zhang Runhui WuXiaoqin FengLin-Hua YangPeng ChengShu ChenYing WangHu ZhouMeijuan HuangYanping SongChenghao JinDonglei ZhangLingling ChenWei LiuLei ZhangFeng XueRenchi Yang

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)

This study reports the largest Chinese cohort of HB inhibitor patients. Large deletions were most significantly associated with inhibitor development. Low-dose ITI might be feasible for FIX inhibitor eradication.

Keyphrases

low dose
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
high dose
emergency department
quality improvement
helicobacter pylori infection